Cardiovascular research focused on metabolic changes that can be altered to prevent disease onset.
Raghav received his B.S. (Biotechnology, 2010) from Indiana University (Bloomington IN), followed by M.S. (Physiology, 2012) from Indiana State University (Terre Haute IN) where he studied angiogenesis in zebrafish doing cancer research. He received his Ph.D. from University of Cincinnati College of Medicine(Cell Biology, 2017) working on cardiovascular regenerative medicine. His thesis involved looking at microRNAs, stem cells, human-iPS derived cardiomyocytes, and other therapeutics that can be used for cardiac regeneration post ischemic injury.